AVEO Pharmaceuticals (AVEO) jumps as EU gives go-ahead

AVEO Pharmaceuticals, Inc. AVEO shares rose 11.6% to $2.59 after the company received the EU regulatory guidance regarding potential MAA for Tivozanib. Share volume was 13 million, compared to an all-day average of 3.8 million
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!